All Relations between Haloperidol and dopamine

Publication Sentence Publish Date Extraction Date Species
K Lankford, F G De Mello, W L Klei. A transient embryonic dopamine receptor inhibits growth cone motility and neurite outgrowth in a subset of avian retina neurons. Neuroscience letters. vol 75. issue 2. 1987-06-16. PMID:2952906. the effects of dopamine could be blocked or reversed by haloperidol or sch23390 and forskolin produced a response similar to dopamine, indicating the morphological changes were mediated by d1-receptor stimulation of adenylate cyclase. 1987-06-16 2023-08-11 Not clear
A A Letter, K Merchant, J W Gibb, G R Hanso. Effect of methamphetamine on neurotensin concentrations in rat brain regions. The Journal of pharmacology and experimental therapeutics. vol 241. issue 2. 1987-06-12. PMID:3572804. these meth-induced increases in ntli concentrations were attenuated by coadministration of haloperidol in the substantia nigra, hypothalamus and hippocampus, indicating a possible involvement of dopamine receptors in these tissues. 1987-06-12 2023-08-11 rat
J W Van der Laa. Dopaminergic and alpha 1-adrenergic properties of B-HT920 revealed in morphine-dependent rats. Pharmacology, biochemistry, and behavior. vol 26. issue 2. 1987-06-02. PMID:2883663. the effects of b-ht920 have been specified using the alpha-adrenergic antagonists yohimbine and prazosin and the dopamine antagonist haloperidol. 1987-06-02 2023-08-11 rat
K Yamaguchi, T Nabeshima, T Kameyam. Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior. Journal of pharmacobio-dynamics. vol 9. issue 12. 1987-06-01. PMID:3033192. the locomotor stimulation induced by intraperitoneal injection of pcp (5 mg/kg) was markedly enhanced by a small dose of methamphetamine and, by contrast, attenuated by reserpine, 6-hydroxydopamine, haloperidol, pimozide and a low dose of apomorphine which inhibits the release of dopamine by the stimulation of presynaptic receptors. 1987-06-01 2023-08-11 Not clear
J M Van Ree, N Ramse. The dopamine hypothesis of opiate reward challenged. European journal of pharmacology. vol 134. issue 2. 1987-05-29. PMID:3032655. the dopamine hypothesis of opiate reward was directly tested by blocking dopamine receptor systems with haloperidol. 1987-05-29 2023-08-11 rat
D D Rasmussen, J H Liu, P L Wolf, S S Ye. Neurosecretion of human hypothalamic immunoreactive beta-endorphin: in vitro regulation by dopamine. Neuroendocrinology. vol 45. issue 3. 1987-05-21. PMID:2951610. an in vitro perifusion system was used to investigate immunoreactive beta-endorphin (beta-end-i) release from adult human hypothalami in response to dopamine (da) and the da receptor antagonist haloperidol (hal). 1987-05-21 2023-08-11 human
M E Trulson, K Araste. Phencyclidine suppresses the activity of midbrain dopamine-containing neurons recorded from mouse brain slices in vitro. European journal of pharmacology. vol 133. issue 3. 1987-05-20. PMID:3556396. the suppression of dopamine neuronal activity by phencyclidine was blocked by pretreatment of the animals with alpha-methyl-para-tyrosine or haloperidol. 1987-05-20 2023-08-11 mouse
Y G Gelder. Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate. International clinical psychopharmacology. vol 1 Suppl 1. 1987-05-08. PMID:3559159. haloperidol, a pharmacologically active molecule characterised by selective dopamine antagonism, was detectable in plasma within one hour after dosing. 1987-05-08 2023-08-11 human
M E Trulson, T J Trulso. Recording of mouse ventral tegmental area dopamine-containing neurons. Experimental neurology. vol 96. issue 1. 1987-05-07. PMID:2881804. systemic administration of the dopamine agonist, apomorphine, decreased their firing rate, and the dopamine receptor blocker, haloperidol, reversed this effect. 1987-05-07 2023-08-11 mouse
S M Pellis, V C Pellis, D P O'Brien, F de la Cruz, P Teitelbau. Pharmacological subtraction of the sensory controls over grasping in rats. Physiology & behavior. vol 39. issue 1. 1987-05-04. PMID:3562646. haloperidol, a dopamine antagonist, abolishes visually elicited reaching and grasping, but leaves intact tactile and proprioceptive control of grasping. 1987-05-04 2023-08-11 rat
R F Lane, C D Blah. Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action. Brain research bulletin. vol 18. issue 1. 1987-05-04. PMID:3828839. chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action. 1987-05-04 2023-08-11 rat
R F Lane, C D Blah. Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action. Brain research bulletin. vol 18. issue 1. 1987-05-04. PMID:3828839. the effects of chronic haloperidol administration on the basal release of endogenous dopamine (da) in the intact rat striatum and nucleus accumbens were investigated using in vivo electrochemical techniques. 1987-05-04 2023-08-11 rat
L A Chiodo, B S Bunne. Population response of midbrain dopaminergic neurons to neuroleptics: further studies on time course and nondopaminergic neuronal influences. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 7. issue 3. 1987-04-29. PMID:2881987. acute oral administration of haloperidol (0.5 mg/kg) results, within 1 hr of administration, in an increase in both the firing rate and number of spontaneously active dopamine neurons encountered in both a9 and a10 regions. 1987-04-29 2023-08-11 Not clear
A D Sherman, J Mot. Effects of glutaminase inhibition on release of endogenous glutamic acid. Neuropharmacology. vol 25. issue 12. 1987-04-29. PMID:2882437. dopamine itself affected neither the release of glutamate nor its blockade by haloperidol even in extremely large concentrations. 1987-04-29 2023-08-11 Not clear
P Buydens, B Velkeniers, J Golstein, E Finné, L Vanhaels. Opioid modulation of thyrotropin releasing hormone induced prolactin secretion. Life sciences. vol 40. issue 12. 1987-04-28. PMID:3104708. pretreatment of the animals with -methyl-parathyrosine resulting in a dopamine depletion or with haloperidol, a dopamine antagonist, could not induce lactotroph responsiveness to trh. 1987-04-28 2023-08-11 rat
H Nishikawa, K Yokotani, M Fujiwar. Catecholamine receptors involved in the inhibitory effects of dopamine on vagally stimulated gastric acid secretion and mucosal blood flow in rats. The Journal of pharmacology and experimental therapeutics. vol 240. issue 3. 1987-04-27. PMID:3031280. haloperidol abolished the inhibitory effect of dopamine on the acid secretion; it also abolished the inhibitory effect of norepinephrine on the vagally stimulated acid secretion. 1987-04-27 2023-08-11 rat
G A Gudelsky, J I Koenig, M Simonovic, T Koyama, T Ohmori, H Y Meltze. Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat. Journal of neural transmission. vol 68. issue 3-4. 1987-04-27. PMID:3104536. differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat. 1987-04-27 2023-08-11 rat
G A Gudelsky, J I Koenig, M Simonovic, T Koyama, T Ohmori, H Y Meltze. Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat. Journal of neural transmission. vol 68. issue 3-4. 1987-04-27. PMID:3104536. clozapine, but neither fluperlapine nor haloperidol, produced a rapid increase in the activity of tuberoinfundibular dopamine (tida) neurons, as evidenced by an enhanced accumulation of dihydroxyphenylalanine (dopa) in the median eminence after the inhibition of dopa decarboxylase. 1987-04-27 2023-08-11 rat
b' T Antakly, S Mercille, J P C\\xc3\\xb4t\\xc3\\xa. Tissue-specific dopaminergic regulation of the glucocorticoid receptor in the rat pituitary. Endocrinology. vol 120. issue 4. 1987-04-27. PMID:3830059.' the dopamine antagonist haloperidol blocks the inhibitory effects of the dopamine agonist. 1987-04-27 2023-08-11 rat
J J Balsara, N V Nandal, V P Gada, T R Bapat, A G Chandorka. Antagonism of bromocriptine-induced cage climbing behaviour in mice by the selective D-2 dopamine receptor antagonists, metoclopramide and molindone. Indian journal of physiology and pharmacology. vol 30. issue 1. 1987-04-23. PMID:2950056. pretreatment with haloperidol, an antagonist of both d-1 and d-2 dopamine receptors, metoclopramide and molindone, the selective d-2 dopamine receptor antagonists, effectively antagonised bromocriptine-induced climbing behaviour. 1987-04-23 2023-08-11 mouse